Clinical Trials Sponsored by MelCure SA

Total 1065 results

Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation and Pain

Pain | Inflammation | Cataract

United States
Xigen SA

Completed

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Pain | Inflammation | Cataract

United States
Teoxane SA

Completed

TEOSYAL® PureSense Redensity [I] Injection Using MicronJet® Needle in the Treatment of Crow's Feet Wrinkles

Crow's Feet Wrinkles

Switzerland
Luzitin SA

Unknown

Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer

Head and Neck Cancer

Portugal
Creabilis SA

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of CT327 in Atopic Dermatitis

Atopic Dermatitis

United Kingdom
PregLem SA

Unknown

A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids (PREMYA)

Uterine Fibroids

United Kingdom, Spain, Italy, France, Germany, Austria, Hungary, Poland, Portugal, Romania
PregLem SA

Completed

PGL2001 Proof of Concept Study in Symptomatic Endometriosis (AMBER)

Endometriosis

Hungary, Romania, Poland
Cytheris SA

Terminated

Study on Interleukin-7 (CYT107) in HIV Patients (Inspire 2)

HIV

United States, Canada
PregLem SA

Completed

PGL4001 Versus GnRH-agonist in Uterine Myomas (PEARLII)

Uterine Myomas

Spain, Germany, Austria, Israel, Poland, Italy, Belgium, France, Netherlands
Creabilis SA

Withdrawn

CT 327 in the "Atopy Patch Test" Model (CT327 AD01-09)

Atopic Dermatitis

Germany
Creabilis SA

Completed

CT 327 in the Treatment of Psoriasis Vulgaris

Psoriasis

Switzerland, United States, United Kingdom
Measure Labs, Inc.
Duke University

Recruiting

Discharge Readmission Analysis and Management in Sepsis (DReAMS-2)

Sepsis

United States
Medicure
SCRI Development Innovations, LLC

Completed

Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention (SAVI-PCI)

Myocardial Infarction | Unstable Angina | Acute Coronary Syndromes

United States
Medicure
SCRI Development Innovations, LLC

Withdrawn

Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention (ATLAST-PCI)

Myocardial Infarction | Percutaneous Coronary Intervention | Unstable Angina | Acute Coronary Syndromes
Debiopharm International SA

Recruiting

A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer

Prostate Cancer

United States
Auregen Biotherapeutics, SA

Recruiting

Long-Term Follow-Up Study of Unilateral Microtia Patients Implanted With AUR-201 (AUR-201)

Microtia

United States
Auregen Biotherapeutics, SA

Recruiting

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (AUR-201)

Microtia

United States
Ichnos Sciences SA

Not yet recruiting

Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma

Relapsed/Refractory Multiple Myeloma

Australia
Medacta International SA

Recruiting

Monocer AOANJRR Registry-nested Study

Survival, Prosthesis

Australia
Rose Pharma SA

Recruiting

An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

Esthetics

Italy
Biosensors Europe SA

Recruiting

ALPHA LONG Study- BioMatrix AlphaTM Stent Study in Patients With CAD

Coronary Artery Disease

United Kingdom
Debiopharm International SA

Recruiting

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

Astrocytoma, Grade III | Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

Spain, United States, Switzerland
Medacta International SA

Recruiting

Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty

Arthritis | Avascular Necrosis | Traumatic Arthritis

Austria
EP Solutions SA

Recruiting

Improving CRT Outcome With Non-Invasive Cardiac Mapping (ICONIC-M)

Heart Failure With Reduced Ejection Fraction

Sweden, Netherlands, Portugal, United Kingdom
Medesis Pharma SA

Recruiting

Clinical Safety and Efficacy Evaluation of NanoLithium® NP03 in Patients With Mild-to-severe Alzheimer's Disease (NanoLi®_AD)

Alzheimer's Disease

France
Ryvu Therapeutics SA

Recruiting

RVU120 (SEL120) in Patients With Relapse/Refractory Metastatic or Advanced Solid Tumors

Advanced Solid Tumor

Spain, Poland
Miracor Medical SA

Recruiting

A Study to Evaluate Safety and Feasibility of PiCSO Therapy in Patients With ST Elevation Inferior Wall Myocardial Infarction. (PiCSO-AMI-V)

Inferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction

France, United Kingdom, Latvia, Switzerland, Denmark
Sword Health, SA

Recruiting

SWORD Health Patient Registry

Musculoskeletal Diseases

Portugal
Symbios Orthopedie SA

Recruiting

A Post-market Observational ORIGIN® vs. VANGUARD® PS Clinical Study

Arthroplasty | Knee | Replacement

Germany
Miracor Medical SA

Not yet recruiting

Observational Registry to Evaluate Real World Usage of PiCSO Impulse System in STEMI Patients as Part of Post-marketing Surveillance (PiCSO-AMI-IV)

STEMI - ST Elevation Myocardial Infarction | Anterior MI

Germany
Celyad Oncology SA

Recruiting

Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02 (CYCLE-1)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

Belgium, United States
Sword Health, SA

Not yet recruiting

Clinical Impact of a Digital Home-based Falls Prevention Program on Elderly People

Fall

Portugal
Medacta International SA

Recruiting

Clinical and Radiological Outcomes of Medacta Shoulder System

Avascular Necrosis | Fracture | Primary Osteoarthritis | Secondary Osteoarthritis | Rotator Cuff Tear Arthropathy | Rheumatoid Arthritis Shoulder | Revision of Shoulder Arthroplasty

Switzerland, France, Germany
Medacta International SA

Recruiting

The Medacta International SMS Post-Marketing Surveillance Study

Arthrosis | Congenital Hip Dysplasia | Traumatic Arthritis | Rheumatoid Polyarthritis | Avascular Necrosis of the Femoral Head

Austria, Italy, Switzerland, United Kingdom
Debiopharm International SA

Completed

Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL

Diffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's Lymphoma

United States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
Auregen Biotherapeutics, SA

Enrolling by invitation

Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia (Australia) (AUR-201)

Microtia

Australia
AB Biotics, SA

Completed

Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners (AB-ULTRA)

Signs and Symptoms

Spain
Polares Medical SA

Terminated

Early Feasibility EXperience of Posterior Leaflet RestOration to REduce Mitral Regurgitation (EXPLORE MR)

Mitral Regurgitation | Mitral Valve Insufficiency | Mitral Valve Disease

Switzerland, Germany
Legacy Healthcare SA

Completed

Efficacy and Safety of LH-8 in Paediatric Alopecia Areata (AA)

Alopecia Areata | Pediatric Disorder

France, Germany, Bulgaria
Medacta International SA

Active, not recruiting

Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Rheumatoid Arthritis | Avascular Necrosis | Congenital Hip Dysplasia | Primary Osteoarthritis | Secondary Osteoarthritis | Traumatic Arthritis | Fracture; Femur, Head

France
Mabion SA
Parexel

Withdrawn

MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis (MABRIDGE)

Rheumatoid Arthritis
AB Biotics, SA

Completed

Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers

Healthy

Spain
Aptissen SA
Noblewell

Completed

An Effectiveness and Safety 6 Months Study of 3 Injections One Week Apart of SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Osteo Arthritis Knee

Poland
Aptissen SA
Noblewell

Completed

An Efficacy and Safety 6-months Study of SYNOLIS VA 80/160 and SYNOLIS VA 40/80 in the Treatment of Symptomatic Knee Osteoarthritis

Osteoarthritis, Knee

Poland
Medacta International SA

Active, not recruiting

RSA Masterloc Study Australia

Radiostereometric Analysis

Australia
Miracor Medical SA

Withdrawn

A Study to Evaluate the Safety and Efficacy of PiCSO in Anterior STEMI Patients (PiCSO-AMI-II)

Anterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction
Medacta International SA

Completed

AMIStem-H Radiographic Analysis

Arthroplasty | Hip | Replacement

Switzerland
Biosensors Europe SA

Completed

Study to Evaluate the Safety and Effectiveness of the Biosensors Microcatheter in Coronary Chronic Total Occlusions (CTO) - BIOMICS (BIOMICS)

Ischemic Heart Disease

United Kingdom
Contrad Swiss SA

Completed

Evaluation of the Effect of the "CR500 SINGLE-DOSE GEL" Medical Device in Patients With Knee Osteoarthritis (KOA)

Knee Osteoarthritis

Italy
Quantum Genomics SA

Completed

Firibastat in Treatment-resistant Hypertension (FRESH)

Hypertension

United States, Czechia, France, Germany, Poland, Spain

Clinical Trials Sponsored by MelCure SA

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations